GBIM

GlobeImmune, Inc. GBIM

GBIM
GlobeImmune, Inc. SYVC
Synovics Pharmaceuticals, Inc. NTII
Neurobiological Technologies, Inc. CMRA
Comera Life Sciences Holdings, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. ANTH
Anthera Pharmaceuticals, Inc. RBSH
Rebus Holdings, Inc. OVIT
OncoVista Innovative Therapies, Inc. FPMI
FluoroPharma Medical, Inc. PZRXQ
PhaseRx, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GBIM SYVC NTII CMRA SNNAQ ANTH RBSH OVIT FPMI PZRXQ
6M -80.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % 100.00 % 100.00 % 0.00 %
YTD -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % -50.00 % -50.00 % 0.00 % 100.00 % -50.00 %
1Y -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % -50.00 % 0.00 % 0.00 % 100.00 % -50.00 %
3Y -85.71 % 0.00 % 0.00 % -99.99 % 0.00 % 0.00 % -98.73 % 0.00 % -86.67 % 0.00 %
5Y -99.97 % 0.00 % -93.33 % -100.00 % -98.44 % -99.54 % -99.98 % -99.25 % -94.44 % -96.15 %
10Y -100.00 % 0.00 % -99.44 % -100.00 % -100.00 % -100.00 % -100.00 % -99.88 % -99.93 % -100.00 %
From the beginning -100.00 % 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.99 % -99.98 % -100.00 %

Dividend

Neurobiological Technologies, Inc.